Company Profiles

driven by the PitchBook Platform

HeMemics Biotechnologies

PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$107k LATEST DEAL AMOUNT
$107k TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of preserved, dried cellular products for diagnostic and therapeutic applications in the veterinary market. The company provides customized technology to clients that need to stabilize their products in dried/non-dried, instead of frozen format, for ease of storage and transportation.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
12111 Parklawn Drive
Rockville, MD 20852
United States

+1 (301) 560-0415
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HeMemics Biotechnologies’s full profile, request a free trial.

HeMemics Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 13-Aug-2007 $107k $107k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

HeMemics Biotechnologies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0

HeMemics Biotechnologies Executive Team (3)

Name Title Board
Seat
Contact
Info
David Ho Ph.D Chief Executive Officer & Chief Scientific Officer
Bruce Campbell President & Chief Operating Officer
Stephen Bruttig Ph.D Chairman & Founder

HeMemics Biotechnologies Board Members (1)

Name Representing Role Since Contact
Info
Stephen Bruttig Ph.D HeMemics Biotechnologies Chairman & Founder 000 0000